Skip to main content
Fuso Pharmaceutical Industries,Ltd. logo

Fuso Pharmaceutical Industries,Ltd. — Investor Relations & Filings

Ticker · 4538 ISIN · JP3823600006 T Manufacturing
Open in API
Filings indexed 65 across all filing types
Latest filing 2025-11-12 Regulatory Filings
Country JP Japan
Listing T 4538

About Fuso Pharmaceutical Industries,Ltd.

https://www.fuso-pharm.co.jp/en/

Fuso Pharmaceutical Industries, Ltd. is a company engaged in the development, manufacture, and sale of pharmaceuticals and medical equipment. The company's core business centers on providing essential medical products, with a primary focus on infusions, such as transfusion fluids, and solutions for artificial kidney dialysis. Its portfolio also includes a wide range of injectables for various therapeutic applications. In addition to supplying prescription drugs to medical institutions, Fuso Pharmaceutical Industries also develops and markets over-the-counter (OTC) medications. The company maintains a commitment to research and development, actively managing a drug pipeline and conducting clinical trials to introduce new treatments.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a previously filed semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 103
2025-11-12 Japanese
半期報告書－第103期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Fuso Pharmaceutical Industries, Ltd. in Japan. It contains detailed financial statements (Balance Sheet, etc.), management analysis of financial conditions, and business results for the interim period ending September 30, 2025. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-11-12 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being filed pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following the resolutions passed at the Annual General Meeting (AGM) held on June 25, 2025. Section 2 details the resolutions, including dividend amounts and the election of directors. This structure—a formal report detailing the results of a shareholder meeting (AGM) resolutions—perfectly matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA). Although it relates to the AGM, the primary content is the *results* of the voting, not the presentation materials (AGM-R) or the proxy solicitation (DEF 14A/PSI). The document length is relatively short (2628 chars), suggesting it is an announcement/filing of results rather than the full AGM presentation.
2025-06-26 Japanese
内部統制報告書－第102期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) in the header section. It explicitly references compliance with the Financial Instruments and Exchange Act ("金融商品取引法第24条の４の４第１項") and details the scope, criteria, and procedures for evaluating internal controls over financial reporting, concluding with an assessment of effectiveness as of the fiscal year-end (March 31, 2025). This structure and content strongly indicate a formal report on internal controls, which aligns best with the 'Audit Report / Information' category (AR), as it deals with internal controls and assurance standards, even though it is not a traditional external audit report. It is a mandatory internal control assessment report required under Japanese regulations, similar in nature to the Sarbanes-Oxley Section 404 report in the US, which often falls under the AR classification in broad financial databases when a specific 'Internal Control Report' code is unavailable. Given the options, AR is the closest fit for a comprehensive internal control assessment document.
2025-06-24 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is titled '確認書' (Confirmation Document) and explicitly references the '金融商品取引法' (Financial Instruments and Exchange Act) and the '有価証券報告書' (Annual Securities Report, equivalent to a 10-K in substance for Japanese filings) for the period ending March 31, 2025. The content is a formal confirmation by the CEO (代表取締役社長) that the contents of the Annual Securities Report are appropriate and comply with relevant laws. This type of formal confirmation document, often filed alongside or immediately following a major annual filing like a 10-K, does not fit neatly into the primary report categories (10-K, IR, ER). Since it is a specific regulatory confirmation related to the annual filing process and doesn't match any other specific category (like AGM, DIRS, DIV, etc.), it falls best under the general 'Regulatory Filings' fallback category (RNS), as it is a required regulatory submission confirming accuracy. FY 2025
2025-06-24 Japanese
有価証券報告書－第102期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report filed by Japanese companies with the Financial Services Agency (Kanto Local Finance Bureau). It contains comprehensive financial data, management discussion, and corporate information for the fiscal year ending March 31, 2025. This corresponds to the 10-K filing category in the provided schema. FY 2025
2025-06-24 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.